1. Home
  2. TAIT vs CVKD Comparison

TAIT vs CVKD Comparison

Compare TAIT & CVKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TAIT
  • CVKD
  • Stock Information
  • Founded
  • TAIT 1989
  • CVKD 2022
  • Country
  • TAIT United States
  • CVKD United States
  • Employees
  • TAIT N/A
  • CVKD N/A
  • Industry
  • TAIT Electronic Components
  • CVKD Medicinal Chemicals and Botanical Products
  • Sector
  • TAIT Technology
  • CVKD Health Care
  • Exchange
  • TAIT Nasdaq
  • CVKD Nasdaq
  • Market Cap
  • TAIT 17.2M
  • CVKD 17.1M
  • IPO Year
  • TAIT 1995
  • CVKD 2023
  • Fundamental
  • Price
  • TAIT $2.86
  • CVKD $16.30
  • Analyst Decision
  • TAIT
  • CVKD Strong Buy
  • Analyst Count
  • TAIT 0
  • CVKD 2
  • Target Price
  • TAIT N/A
  • CVKD $52.50
  • AVG Volume (30 Days)
  • TAIT 4.8K
  • CVKD 50.4K
  • Earning Date
  • TAIT 11-12-2024
  • CVKD 11-08-2024
  • Dividend Yield
  • TAIT 6.97%
  • CVKD N/A
  • EPS Growth
  • TAIT N/A
  • CVKD N/A
  • EPS
  • TAIT 0.25
  • CVKD N/A
  • Revenue
  • TAIT $4,719,000.00
  • CVKD N/A
  • Revenue This Year
  • TAIT N/A
  • CVKD N/A
  • Revenue Next Year
  • TAIT N/A
  • CVKD N/A
  • P/E Ratio
  • TAIT $11.52
  • CVKD N/A
  • Revenue Growth
  • TAIT N/A
  • CVKD N/A
  • 52 Week Low
  • TAIT $2.57
  • CVKD $5.40
  • 52 Week High
  • TAIT $3.65
  • CVKD $32.55
  • Technical
  • Relative Strength Index (RSI)
  • TAIT 45.09
  • CVKD 70.84
  • Support Level
  • TAIT $2.85
  • CVKD $11.19
  • Resistance Level
  • TAIT $2.91
  • CVKD $15.93
  • Average True Range (ATR)
  • TAIT 0.04
  • CVKD 1.30
  • MACD
  • TAIT -0.01
  • CVKD 0.22
  • Stochastic Oscillator
  • TAIT 16.94
  • CVKD 97.25

About TAIT Taitron Components Incorporated

Taitron Components Inc is a supplier of originally designed and manufactured (ODM) products that include value-added engineering and turn-key solutions. It focuses on providing original equipment manufacturers (OEMs) and contracts electronic manufacturers (CEMs) with ODM products for their multi-year turn-key projects and ODM electronic components. The company's product offerings range from discrete semiconductors to small electronic devices. The company also distributes brand-name electronic components with a vast inventory available on hand. Its Taiwan and China locations provide support for inventory sourcing, purchases, and coordinating the manufacture of ODM Projects and ODM Components.

About CVKD Cadrenal Therapeutics Inc.

Cadrenal Therapeutics Inc is focused on developing a novel therapy with orphan drug indication, tecarfarin, for the prevention of systemic thromboembolism (blood clots) of cardiac origin in patients with end-stage renal disease (on dialysis) and atrial fibrillation (irregular heartbeat) or AFib. Tecarfarin is an anticoagulant designed using a drug design process that targets a different pathway than most commonly prescribed drugs for the treatment of thrombosis and AFib.

Share on Social Networks: